• Explore /
  • Poster
  • / Dynamic circulating tumor DNA (ctDNA) in monitoring trastuzumab deruxtecan (TDXd) activity for patients (pts) with advanced breast cancer: Preliminary results of a feasibility study.

Dynamic circulating tumor DNA (ctDNA) in monitoring trastuzumab deruxtecan (TDXd) activity for patients (pts) with advanced breast cancer: Preliminary results of a feasibility study.

Abstract Poster

Authors

null

Elena Giordani

Regina Elena National Cancer Institute, Rome, Italy

Elena Giordani , Antonella Palazzo , Angelo Minucci , Francesco Pavese , Ida Paris , Elisa De Paolis , Elena Ricciardi , Armando Orlandi , Sergio Pannunzio , Giordana Tiberi , Luisa Carbognin , Emilio Bria , Diana Giannarelli , Giovanni Scambia , Patrizio Giacomini , Alessandra Fabi

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Breast Cancer—Metastatic

Track

Breast Cancer

Sub Track

HER2-Positive

Citation

J Clin Oncol 40, 2022 (suppl 16; abstr 1046)

DOI

10.1200/JCO.2022.40.16_suppl.1046

Abstract #

1046

Poster Bd #

424

Abstract Disclosures

Similar Posters

First Author: Jenny Furlanetto

First Author: Vincent T. Ma

Poster

2024 ASCO Genitourinary Cancers Symposium

Novel molecular aberrations involved in testicular germ cell tumor (TGCT) development and cisplatin resistance.

Novel molecular aberrations involved in testicular germ cell tumor (TGCT) development and cisplatin resistance.

First Author: Ludmila Boublikova

First Author: Ilyas Sahin